MRG007
MRG007-001/ARR-217-101
Phase 1 small_molecule active
Quick answer
MRG007 for Locally Advanced or Metastatic Solid Tumors is a Phase 1 program (small_molecule) at ArriVent BioPharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ArriVent BioPharma
- Indication
- Locally Advanced or Metastatic Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active